Details of the Drug Excipient

General Information of Drug Inactive Ingredient (DIG) (ID: E00687)

DIG Name
Ammonium hydroxide
DIG Function
Alkalizing agent

Full List of Drug(s) Co-administrated with This DIG

4 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Cabozantinib DMIYDT4 Medullary thyroid gland carcinoma [] Cabozantinib S-Malate eq 80mg base capsule F23394
Cysteamine DMSYFM8 Nephropathic cystinosis [5C60] Cysteamine Bitartrate eq 50mg base capsule F23414
Raltegravir DMYURI6 Human immunodeficiency virus infection [1C62] Raltegravir Potassium eq 100mg base/packet powder F23528
Talazoparib DM1KS78 Breast cancer [2C60-2C65] Talazoparib 0.25 mg capsule F24298
------------------
1 Clinical Trial Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Selumetinib DMC7W6R Neurofibromatosis type 1 [LD2D.10] Selumetinib 10 mg capsule F23891
------------------